Manufacturing

Apr 05, 2018
By BioPharm International Editors
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.
Apr 01, 2018
BioPharm International
Developments and investments in single-use systems advance upstream biomanufacturing.
Apr 01, 2018
BioPharm International
Updated guidelines and new technologies aid visual inspection of parenteral products and packaging.
Mar 29, 2018
By BioPharm International Editors
The companies will co-develop and co-promote a CAR T cell therapy in the United States.
Mar 26, 2018
By BioPharm International Editors
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
Mar 26, 2018
By BioPharm International Editors
The agreement gives IncoCell Tianjin, a wholly-owned subsidiary of China-based Boyalife Group, access to Cesca’s celluar processing contract development and manufacturing services.
Mar 23, 2018
By BioPharm International Editors
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
Mar 22, 2018
By BioPharm International Editors
The company plans to install 4000-L disposable bioreactors from ABEC at its new commercial manufacturing facility in Wuxi city, China.
Mar 20, 2018
By BioPharm International Editors
ISPE announced BioMarin Pharmaceutical, Shire, Vetter, and Wyeth Pharmaceuticals as FOYA Category winners.
Mar 19, 2018
By BioPharm International Editors
Sartorius Stedim Biotech has launched a new automated parallel bioreactor system for perfusion culture.
native1_300x100
lorem ipsum